Penile cancer
Results
Phase 2
This trial looked at the chemotherapy combination of docetaxel, cisplatin and fluorouracil for cancer of the penis. This trial was supported by Cancer Research UK.
Recruitment start: 28 August 2009
Recruitment end: 23 December 2010
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Amit Bahl Dr Steve Nicolson
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Institute of Cancer Research (ICR)
Sanofi-Aventis (Supply of Docetaxel)
University Hospitals Bristol NHS Foundation Trust
This is Cancer Research UK trial number CRUK/09/001.
Last reviewed: 25 August 2014
CRUK internal database number: 1035